AI and Cloud Adoption Push North America Biological Data Visualization to $665.6 Million by 2035

North America biological data visualization market stood at $281.5 million in 2025 and is expected to expand to $665.6 million by 2035, registering a CAGR of 9.1% over the 2026 to 2035 period. AI-driven analytics and scalable cloud platforms are transforming biological data visualization workflows across North America. Research groups, pharmaceutical and biotech organizations, and academic labs are increasingly adopting tools that embed machine learning and cloud-native capabilities directly into visualization systems. These technologies automate pattern recognition, accelerate interpretation of complex datasets such as single-cell profiles and multiomic outputs, and enable collaboration across distributed teams. AI helps reduce the manual burden of interpreting high-dimensional data generated from sequencing, microscopy, and spatial biology techniques, while cloud-based access supports flexible, scalable analysis environments that enhance throughput and reproducibility.

Browse the full report description of “North American Biological Data Visualization Market Size, Share & Trends Analysis Report by Technique (Magnetic Resonance Imaging, Microscopy, Sequencing, and Others), By Application (Genomic Analysis, Cell Biology, Molecular & Structural Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, Hospitals and Clinics) Forecast Period 2026-2035” at https://www.omrglobal.com/industry-reports/north-american-biological-data-visualization-market

This shift toward AI- and cloud-enabled visualization is reflected in a few major platform developments across North America. Benchling has integrated AI directly into its scientific platform to support in-platform data visualization and predictive analysis, while Deepcell’s REM-I platform applies AI to imaging-based visualization of single-cell morphology. In parallel, BD Biosciences has expanded the capabilities of its Cellismo software to support more advanced interactive visualization of single-cell multiomics data, underscoring rising demand for tools that can manage complex biological datasets at scale.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • Technique
  • Application
  • End-User
• Competitive Landscape – Agilent Technologies, Inc., Bruker Corp., GE HealthCare Technologies Inc., Illumina, Inc., Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

North America Biological Data Visualization Market Report Segment

By Technique

• Magnetic Resonance Imaging
• Microscopy
• Sequencing
• Others

By Application

• Genomic Analysis
• Cell Biology
• Molecular and Structural Analysis
• Others

By End-User

• Pharmaceutical & Biotechnology Companies
• Research Institutes
• Hospitals and Clinics

North America Biological Data Visualization Market Report Segment by Country

• United States
• Canada

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-biological-data-visualization-market